CLEAR III. Clot lysis: evaluating accelerated resolution of intraventricular hemorrhage - CLEAR III

Phase 1

• Conditions: Hemorragia intraventricular de causa espontánea secundaria a patología vascular cerebral; MedDRA version: 9Level: LLTClassification code 10022840Term: Intraventricular haemorrhage

• Registration Number: EUCTR2008-006916-39-ES
• Lead Sponsor: Johns Hopkins University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2009-09-15
• Last Update Posted: 30 May 2016

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: 180

Inclusion Criteria

edad entre 18 y 80 años
hemorragia intracerebral < o = a 30 cc
hemorragia intraventricular obstructiva del III y/o del IV ventrículo
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Espectativa de vida menor de 48 horas
malformación vascular cerebral no tratada
alteración de la coagulación
embarazo
hemorragia de fosa posterior
hemorragia en el trayecto del cateter ventricular

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified